跳至主要内容
临床试验/JPRN-UMIN000003385
JPRN-UMIN000003385已完成未知

A prospective surveillance of cardiovascular events in antiplatelet-treated arteriosclerosis obliterans patients in Japan. - SEASO

Mitsubishi Tanabe Pharma Corporation0 个研究点目标入组 11,375 人开始时间: 2010年3月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
11,375

研究概览

简要总结

<Journal Articles> -Int Heart J. 51(5):337-42,2010. -Circ J. 80(3):712-21,2016. -Scientific Reports 7(1):6095,2017. -Angiology Nov26,2018. -Circ J. 83(9):1029-36,2019. <Scientific Conference> -The Annual Meeting of Japanese College of Angiology 53rd (2012) 54th (2013) 55th (2014) -The Annual Scientific Meeting of the Japanse Curculation Society 77th (2013) 78th (2014) 79th (2015) -European Society of Cardiology (2015)

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • The following subjects were excluded: (1)Those with contraindications to the use of targeted medication (sarpogrelate or antiplatelet agents). (2)Those considered inappropriate for the study by patient's physicians.

研究者

相似试验